nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLC7A11—forelimb zeugopod—sarcoma	0.0557	0.217	CbGeAlD
Acetylcysteine—ACY1—skin of body—sarcoma	0.0098	0.0381	CbGeAlD
Acetylcysteine—CHUK—hematopoietic system—sarcoma	0.00778	0.0302	CbGeAlD
Acetylcysteine—CHUK—connective tissue—sarcoma	0.00749	0.0291	CbGeAlD
Acetylcysteine—CHUK—skin of body—sarcoma	0.00677	0.0263	CbGeAlD
Acetylcysteine—SLCO1B1—mammary gland—sarcoma	0.00626	0.0243	CbGeAlD
Acetylcysteine—ACY1—testis—sarcoma	0.00618	0.024	CbGeAlD
Acetylcysteine—IKBKB—myometrium—sarcoma	0.00616	0.0239	CbGeAlD
Acetylcysteine—GSS—myometrium—sarcoma	0.00605	0.0235	CbGeAlD
Acetylcysteine—IKBKB—embryo—sarcoma	0.00593	0.023	CbGeAlD
Acetylcysteine—ACY1—liver—sarcoma	0.00584	0.0227	CbGeAlD
Acetylcysteine—SLC7A11—smooth muscle tissue—sarcoma	0.00564	0.0219	CbGeAlD
Acetylcysteine—CHUK—lymphoid tissue—sarcoma	0.00548	0.0213	CbGeAlD
Acetylcysteine—GSS—seminal vesicle—sarcoma	0.00546	0.0212	CbGeAlD
Acetylcysteine—IKBKB—hematopoietic system—sarcoma	0.00529	0.0206	CbGeAlD
Acetylcysteine—GRIN2D—tendon—sarcoma	0.00529	0.0205	CbGeAlD
Acetylcysteine—Throat tightness—Etoposide—sarcoma	0.00524	0.0269	CcSEcCtD
Acetylcysteine—GSS—hematopoietic system—sarcoma	0.00519	0.0202	CbGeAlD
Acetylcysteine—IKBKB—connective tissue—sarcoma	0.00509	0.0198	CbGeAlD
Acetylcysteine—Respiratory distress—Vincristine—sarcoma	0.00499	0.0257	CcSEcCtD
Acetylcysteine—IKBKB—smooth muscle tissue—sarcoma	0.00466	0.0181	CbGeAlD
Acetylcysteine—IKBKB—skin of body—sarcoma	0.0046	0.0179	CbGeAlD
Acetylcysteine—GSS—smooth muscle tissue—sarcoma	0.00457	0.0178	CbGeAlD
Acetylcysteine—GSS—skin of body—sarcoma	0.00451	0.0175	CbGeAlD
Acetylcysteine—GRIN2D—testis—sarcoma	0.00438	0.017	CbGeAlD
Acetylcysteine—CHUK—testis—sarcoma	0.00426	0.0166	CbGeAlD
Acetylcysteine—GRIN3A—testis—sarcoma	0.00411	0.016	CbGeAlD
Acetylcysteine—Sensitisation—Epirubicin—sarcoma	0.00403	0.0207	CcSEcCtD
Acetylcysteine—CHUK—liver—sarcoma	0.00403	0.0157	CbGeAlD
Acetylcysteine—IKBKB—uterus—sarcoma	0.004	0.0155	CbGeAlD
Acetylcysteine—GSS—cardiac atrium—sarcoma	0.00394	0.0153	CbGeAlD
Acetylcysteine—GRIN2A—tendon—sarcoma	0.00393	0.0153	CbGeAlD
Acetylcysteine—GSS—uterus—sarcoma	0.00392	0.0152	CbGeAlD
Acetylcysteine—SLCO1B1—hematopoietic system—sarcoma	0.00382	0.0148	CbGeAlD
Acetylcysteine—Sensitisation—Doxorubicin—sarcoma	0.00373	0.0192	CcSEcCtD
Acetylcysteine—IKBKB—lymphoid tissue—sarcoma	0.00372	0.0145	CbGeAlD
Acetylcysteine—SLC7A11—testis—sarcoma	0.00351	0.0136	CbGeAlD
Acetylcysteine—IKBKB—tendon—sarcoma	0.0035	0.0136	CbGeAlD
Acetylcysteine—GSS—tendon—sarcoma	0.00344	0.0134	CbGeAlD
Acetylcysteine—GSS—bone marrow—sarcoma	0.00333	0.0129	CbGeAlD
Acetylcysteine—GRIN2A—testis—sarcoma	0.00325	0.0126	CbGeAlD
Acetylcysteine—Gait disturbance—Vincristine—sarcoma	0.00325	0.0167	CcSEcCtD
Acetylcysteine—CHUK—lymph node—sarcoma	0.00309	0.012	CbGeAlD
Acetylcysteine—Chest discomfort—Etoposide—sarcoma	0.0029	0.0149	CcSEcCtD
Acetylcysteine—IKBKB—testis—sarcoma	0.0029	0.0113	CbGeAlD
Acetylcysteine—GSS—testis—sarcoma	0.00285	0.0111	CbGeAlD
Acetylcysteine—IKBKB—liver—sarcoma	0.00274	0.0107	CbGeAlD
Acetylcysteine—GSS—liver—sarcoma	0.00269	0.0105	CbGeAlD
Acetylcysteine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00232	0.0119	CcSEcCtD
Acetylcysteine—IKBKB—lymph node—sarcoma	0.0021	0.00817	CbGeAlD
Acetylcysteine—GSS—lymph node—sarcoma	0.00206	0.00802	CbGeAlD
Acetylcysteine—SLCO1B1—liver—sarcoma	0.00198	0.00768	CbGeAlD
Acetylcysteine—Stomatitis—Thiotepa—sarcoma	0.00195	0.01	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—sarcoma	0.00195	0.01	CcSEcCtD
Acetylcysteine—Stomatitis—Dactinomycin—sarcoma	0.00194	0.00995	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Etoposide—sarcoma	0.00193	0.00991	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—sarcoma	0.00184	0.00943	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—sarcoma	0.0018	0.00926	CcSEcCtD
Acetylcysteine—Pharyngitis—Dactinomycin—sarcoma	0.00177	0.0091	CcSEcCtD
Acetylcysteine—Stomatitis—Vincristine—sarcoma	0.00173	0.00889	CcSEcCtD
Acetylcysteine—Drowsiness—Mitoxantrone—sarcoma	0.00173	0.00888	CcSEcCtD
Acetylcysteine—Sweating—Vincristine—sarcoma	0.0017	0.00875	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—sarcoma	0.0017	0.00873	CcSEcCtD
Acetylcysteine—Stomatitis—Mitoxantrone—sarcoma	0.00168	0.00866	CcSEcCtD
Acetylcysteine—Cardiac disorder—Thiotepa—sarcoma	0.00167	0.00857	CcSEcCtD
Acetylcysteine—Sweating—Mitoxantrone—sarcoma	0.00166	0.00852	CcSEcCtD
Acetylcysteine—Flushing—Dactinomycin—sarcoma	0.00166	0.00851	CcSEcCtD
Acetylcysteine—Angiopathy—Thiotepa—sarcoma	0.00163	0.00838	CcSEcCtD
Acetylcysteine—Immune system disorder—Thiotepa—sarcoma	0.00162	0.00834	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Thiotepa—sarcoma	0.00162	0.00832	CcSEcCtD
Acetylcysteine—Bronchospasm—Etoposide—sarcoma	0.00159	0.00815	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—sarcoma	0.00157	0.00809	CcSEcCtD
Acetylcysteine—Erythema—Thiotepa—sarcoma	0.00156	0.00804	CcSEcCtD
Acetylcysteine—Erythema—Dactinomycin—sarcoma	0.00155	0.00798	CcSEcCtD
Acetylcysteine—Pharyngitis—Mitoxantrone—sarcoma	0.00154	0.00792	CcSEcCtD
Acetylcysteine—Cardiac disorder—Vincristine—sarcoma	0.00148	0.0076	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—sarcoma	0.00148	0.00759	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—sarcoma	0.00146	0.00748	CcSEcCtD
Acetylcysteine—Angiopathy—Vincristine—sarcoma	0.00145	0.00743	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Vincristine—sarcoma	0.00144	0.00738	CcSEcCtD
Acetylcysteine—Stomatitis—Etoposide—sarcoma	0.0014	0.0072	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—sarcoma	0.00137	0.00702	CcSEcCtD
Acetylcysteine—Cough—Thiotepa—sarcoma	0.00136	0.00702	CcSEcCtD
Acetylcysteine—Erythema—Mitoxantrone—sarcoma	0.00135	0.00694	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00132	0.0068	CcSEcCtD
Acetylcysteine—Oedema—Dactinomycin—sarcoma	0.00127	0.00651	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—sarcoma	0.00125	0.00643	CcSEcCtD
Acetylcysteine—Tachycardia—Thiotepa—sarcoma	0.00125	0.0064	CcSEcCtD
Acetylcysteine—Skin disorder—Thiotepa—sarcoma	0.00124	0.00637	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—sarcoma	0.0012	0.00616	CcSEcCtD
Acetylcysteine—Cardiac disorder—Etoposide—sarcoma	0.0012	0.00616	CcSEcCtD
Acetylcysteine—Cough—Mitoxantrone—sarcoma	0.00118	0.00606	CcSEcCtD
Acetylcysteine—Angiopathy—Etoposide—sarcoma	0.00117	0.00602	CcSEcCtD
Acetylcysteine—Immune system disorder—Etoposide—sarcoma	0.00117	0.00599	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Etoposide—sarcoma	0.00116	0.00598	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—sarcoma	0.00116	0.00595	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—sarcoma	0.00116	0.00595	CcSEcCtD
Acetylcysteine—Somnolence—Thiotepa—sarcoma	0.00113	0.00583	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Vincristine—sarcoma	0.00113	0.00582	CcSEcCtD
Acetylcysteine—Oedema—Vincristine—sarcoma	0.00113	0.00582	CcSEcCtD
Acetylcysteine—Dyspepsia—Thiotepa—sarcoma	0.00112	0.00578	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Mitoxantrone—sarcoma	0.0011	0.00567	CcSEcCtD
Acetylcysteine—Oedema—Mitoxantrone—sarcoma	0.0011	0.00567	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Thiotepa—sarcoma	0.0011	0.00566	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Vincristine—sarcoma	0.00109	0.00562	CcSEcCtD
Acetylcysteine—Shock—Mitoxantrone—sarcoma	0.00108	0.00557	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00108	0.00555	CcSEcCtD
Acetylcysteine—Tachycardia—Mitoxantrone—sarcoma	0.00108	0.00553	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—sarcoma	0.00107	0.00551	CcSEcCtD
Acetylcysteine—Skin disorder—Mitoxantrone—sarcoma	0.00107	0.0055	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00107	0.00548	CcSEcCtD
Acetylcysteine—Hypotension—Vincristine—sarcoma	0.00106	0.00544	CcSEcCtD
Acetylcysteine—Hypotension—Mitoxantrone—sarcoma	0.00103	0.00529	CcSEcCtD
Acetylcysteine—Urticaria—Thiotepa—sarcoma	0.00101	0.00521	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—sarcoma	0.00101	0.00519	CcSEcCtD
Acetylcysteine—Body temperature increased—Thiotepa—sarcoma	0.00101	0.00519	CcSEcCtD
Acetylcysteine—Body temperature increased—Dactinomycin—sarcoma	0.001	0.00515	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.001	0.00514	CcSEcCtD
Acetylcysteine—Loss of consciousness—Etoposide—sarcoma	0.000988	0.00508	CcSEcCtD
Acetylcysteine—Dyspnoea—Mitoxantrone—sarcoma	0.000983	0.00505	CcSEcCtD
Acetylcysteine—Cough—Etoposide—sarcoma	0.00098	0.00504	CcSEcCtD
Acetylcysteine—Somnolence—Mitoxantrone—sarcoma	0.00098	0.00504	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Vincristine—sarcoma	0.000977	0.00502	CcSEcCtD
Acetylcysteine—Dyspepsia—Mitoxantrone—sarcoma	0.00097	0.00499	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00095	0.00488	CcSEcCtD
Acetylcysteine—Hypersensitivity—Thiotepa—sarcoma	0.000941	0.00483	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—sarcoma	0.000935	0.00481	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—sarcoma	0.000934	0.0048	CcSEcCtD
Acetylcysteine—Hypersensitivity—Dactinomycin—sarcoma	0.000933	0.0048	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Etoposide—sarcoma	0.000917	0.00471	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—sarcoma	0.000904	0.00465	CcSEcCtD
Acetylcysteine—Pruritus—Thiotepa—sarcoma	0.000903	0.00464	CcSEcCtD
Acetylcysteine—Tachycardia—Etoposide—sarcoma	0.000895	0.0046	CcSEcCtD
Acetylcysteine—Body temperature increased—Vincristine—sarcoma	0.000895	0.0046	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—sarcoma	0.000891	0.00458	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—sarcoma	0.000886	0.00456	CcSEcCtD
Acetylcysteine—Urticaria—Mitoxantrone—sarcoma	0.000876	0.0045	CcSEcCtD
Acetylcysteine—Body temperature increased—Mitoxantrone—sarcoma	0.000871	0.00448	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—sarcoma	0.000865	0.00445	CcSEcCtD
Acetylcysteine—Hypotension—Etoposide—sarcoma	0.000857	0.0044	CcSEcCtD
Acetylcysteine—Dizziness—Thiotepa—sarcoma	0.000844	0.00434	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—sarcoma	0.000836	0.0043	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vincristine—sarcoma	0.000834	0.00429	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—sarcoma	0.000818	0.0042	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—sarcoma	0.000815	0.00419	CcSEcCtD
Acetylcysteine—Hypersensitivity—Mitoxantrone—sarcoma	0.000812	0.00417	CcSEcCtD
Acetylcysteine—Vomiting—Thiotepa—sarcoma	0.000812	0.00417	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—sarcoma	0.000806	0.00414	CcSEcCtD
Acetylcysteine—Vomiting—Dactinomycin—sarcoma	0.000806	0.00414	CcSEcCtD
Acetylcysteine—Rash—Thiotepa—sarcoma	0.000805	0.00414	CcSEcCtD
Acetylcysteine—Dermatitis—Thiotepa—sarcoma	0.000804	0.00413	CcSEcCtD
Acetylcysteine—Rash—Dactinomycin—sarcoma	0.000799	0.00411	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Etoposide—sarcoma	0.000792	0.00407	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—sarcoma	0.000786	0.00404	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—sarcoma	0.000773	0.00397	CcSEcCtD
Acetylcysteine—Nausea—Thiotepa—sarcoma	0.000758	0.0039	CcSEcCtD
Acetylcysteine—Nausea—Dactinomycin—sarcoma	0.000753	0.00387	CcSEcCtD
Acetylcysteine—Dizziness—Vincristine—sarcoma	0.000749	0.00385	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—sarcoma	0.000746	0.00383	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—sarcoma	0.000728	0.00374	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—sarcoma	0.000727	0.00374	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—sarcoma	0.000725	0.00373	CcSEcCtD
Acetylcysteine—Vomiting—Vincristine—sarcoma	0.00072	0.0037	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—sarcoma	0.000718	0.00369	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—sarcoma	0.000715	0.00367	CcSEcCtD
Acetylcysteine—Rash—Vincristine—sarcoma	0.000714	0.00367	CcSEcCtD
Acetylcysteine—Dermatitis—Vincristine—sarcoma	0.000713	0.00367	CcSEcCtD
Acetylcysteine—Vomiting—Mitoxantrone—sarcoma	0.000701	0.0036	CcSEcCtD
Acetylcysteine—Rash—Mitoxantrone—sarcoma	0.000695	0.00357	CcSEcCtD
Acetylcysteine—Dermatitis—Mitoxantrone—sarcoma	0.000694	0.00357	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etoposide—sarcoma	0.000676	0.00347	CcSEcCtD
Acetylcysteine—Nausea—Vincristine—sarcoma	0.000672	0.00346	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—sarcoma	0.000671	0.00345	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—sarcoma	0.000671	0.00345	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—sarcoma	0.000664	0.00341	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—sarcoma	0.000656	0.00337	CcSEcCtD
Acetylcysteine—Nausea—Mitoxantrone—sarcoma	0.000655	0.00337	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—sarcoma	0.000654	0.00336	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—sarcoma	0.000652	0.00335	CcSEcCtD
Acetylcysteine—Pruritus—Etoposide—sarcoma	0.000649	0.00333	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—sarcoma	0.00063	0.00324	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—sarcoma	0.000621	0.00319	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—sarcoma	0.000621	0.00319	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—sarcoma	0.000607	0.00312	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—sarcoma	0.000606	0.00312	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—sarcoma	0.000605	0.00311	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—sarcoma	0.000603	0.0031	CcSEcCtD
Acetylcysteine—Vomiting—Etoposide—sarcoma	0.000583	0.003	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—sarcoma	0.000583	0.003	CcSEcCtD
Acetylcysteine—Rash—Etoposide—sarcoma	0.000578	0.00297	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—sarcoma	0.000578	0.00297	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—sarcoma	0.000565	0.0029	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—sarcoma	0.000554	0.00285	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—sarcoma	0.00055	0.00282	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—sarcoma	0.000545	0.0028	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000533	0.00274	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—sarcoma	0.000523	0.00269	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—sarcoma	0.000514	0.00264	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—sarcoma	0.000514	0.00264	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—sarcoma	0.000512	0.00263	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—sarcoma	0.000509	0.00261	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—sarcoma	0.000506	0.0026	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—sarcoma	0.000502	0.00258	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—sarcoma	0.000499	0.00257	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—sarcoma	0.000497	0.00255	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000493	0.00253	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—sarcoma	0.00048	0.00247	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—sarcoma	0.000476	0.00244	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—sarcoma	0.000476	0.00244	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—sarcoma	0.000468	0.00241	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—sarcoma	0.000464	0.00239	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—sarcoma	0.000462	0.00237	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—sarcoma	0.00046	0.00236	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—sarcoma	0.000458	0.00236	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—sarcoma	0.000457	0.00235	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—sarcoma	0.000452	0.00233	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—sarcoma	0.000444	0.00228	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000444	0.00228	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—sarcoma	0.000424	0.00218	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—sarcoma	0.000423	0.00217	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—sarcoma	0.000419	0.00215	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000411	0.00211	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—sarcoma	0.000408	0.0021	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—sarcoma	0.000406	0.00209	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—sarcoma	0.000379	0.00195	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—sarcoma	0.000378	0.00194	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—sarcoma	0.000376	0.00193	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—sarcoma	0.000364	0.00187	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—sarcoma	0.00035	0.0018	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—sarcoma	0.00034	0.00175	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—sarcoma	0.000336	0.00173	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—sarcoma	0.000327	0.00168	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—sarcoma	0.000324	0.00167	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—sarcoma	0.000324	0.00166	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—sarcoma	0.000315	0.00162	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—sarcoma	0.000305	0.00157	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—sarcoma	0.000302	0.00155	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—sarcoma	0.0003	0.00154	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—sarcoma	0.0003	0.00154	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—sarcoma	0.000283	0.00145	CcSEcCtD
Acetylcysteine—CHUK—Signaling by PDGF—EGFR—sarcoma	0.000209	0.000382	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NPM1—sarcoma	0.000209	0.000382	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—NRAS—sarcoma	0.000209	0.000381	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	0.000208	0.00038	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—MYC—sarcoma	0.000207	0.000377	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—HRAS—sarcoma	0.000206	0.000376	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000206	0.000376	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000204	0.000372	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—sarcoma	0.000203	0.000371	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—FOXO1—sarcoma	0.000203	0.00037	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—HRAS—sarcoma	0.000203	0.00037	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PDGFRB—sarcoma	0.000202	0.000369	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neuronal System—HRAS—sarcoma	0.000202	0.000369	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—EGFR—sarcoma	0.000202	0.000369	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—KRAS—sarcoma	0.000202	0.000369	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	0.000202	0.000369	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—KRAS—sarcoma	0.000202	0.000369	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000201	0.000367	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—KRAS—sarcoma	0.0002	0.000366	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PDGFRA—sarcoma	0.000199	0.000364	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—KRAS—sarcoma	0.000199	0.000362	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—EGFR—sarcoma	0.000198	0.000361	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—KRAS—sarcoma	0.000198	0.000361	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—HRAS—sarcoma	0.000197	0.00036	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—NRAS—sarcoma	0.000197	0.00036	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—EGFR—sarcoma	0.000195	0.000356	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—FOXO1—sarcoma	0.000195	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PDGFRB—sarcoma	0.000194	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—HRAS—sarcoma	0.000194	0.000354	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—sarcoma	0.000194	0.000354	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL2—sarcoma	0.000194	0.000354	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—MDM2—sarcoma	0.000193	0.000353	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—sarcoma	0.000192	0.00035	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PDGFRA—sarcoma	0.000191	0.000349	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—KRAS—sarcoma	0.000191	0.000349	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.00019	0.000347	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—EGFR—sarcoma	0.00019	0.000347	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—sarcoma	0.00019	0.000346	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—KRAS—sarcoma	0.000187	0.000341	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—KRAS—sarcoma	0.000187	0.000341	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—HRAS—sarcoma	0.000185	0.000338	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—HRAS—sarcoma	0.000184	0.000337	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—KRAS—sarcoma	0.000184	0.000336	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FOXO1—sarcoma	0.000184	0.000336	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—HRAS—sarcoma	0.000184	0.000335	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—HRAS—sarcoma	0.000184	0.000335	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PDGFRB—sarcoma	0.000184	0.000335	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—sarcoma	0.000183	0.000335	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—HRAS—sarcoma	0.000183	0.000333	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ENO2—sarcoma	0.000181	0.00033	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PDGFRA—sarcoma	0.000181	0.00033	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.00018	0.000329	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—KRAS—sarcoma	0.00018	0.000328	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—EGFR—sarcoma	0.00018	0.000328	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	0.000179	0.000327	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—FOXO1—sarcoma	0.000177	0.000322	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—sarcoma	0.000177	0.000322	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PDGFRB—sarcoma	0.000176	0.000322	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL2—sarcoma	0.000176	0.000321	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—CTNNB1—sarcoma	0.000176	0.000321	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PDGFRA—sarcoma	0.000174	0.000317	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—sarcoma	0.000172	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—sarcoma	0.000172	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—sarcoma	0.000172	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.000172	0.000314	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—CTNNB1—sarcoma	0.000171	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—sarcoma	0.00017	0.000311	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTPRC—sarcoma	0.00017	0.00031	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—sarcoma	0.00017	0.00031	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KRAS—sarcoma	0.00017	0.00031	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000169	0.000309	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—sarcoma	0.000169	0.000308	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000169	0.000308	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—sarcoma	0.000168	0.000307	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PLCG1—sarcoma	0.000166	0.000304	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—SRC—sarcoma	0.000166	0.000304	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—sarcoma	0.000166	0.000303	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.000163	0.000298	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NRAS—sarcoma	0.000163	0.000297	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TLE1—sarcoma	0.000162	0.000296	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NRAS—sarcoma	0.00016	0.000292	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—sarcoma	0.000159	0.00029	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—sarcoma	0.000159	0.00029	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—SRC—sarcoma	0.000159	0.00029	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ATF1—sarcoma	0.000158	0.000289	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—sarcoma	0.000157	0.000286	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.000156	0.000284	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—SRC—sarcoma	0.000155	0.000283	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—sarcoma	0.000155	0.000282	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KIT—sarcoma	0.000155	0.000282	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTPRC—sarcoma	0.000154	0.000281	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PLCG1—sarcoma	0.000154	0.00028	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—NRAS—sarcoma	0.000153	0.000279	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—sarcoma	0.000153	0.000279	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	0.000152	0.000278	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PLCG1—sarcoma	0.000151	0.000275	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—SRC—sarcoma	0.000151	0.000275	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—sarcoma	0.000151	0.000275	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—NRAS—sarcoma	0.000149	0.000272	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KIT—sarcoma	0.000148	0.000271	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CXCR4—sarcoma	0.000148	0.000269	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NRAS—sarcoma	0.000148	0.000269	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TLE1—sarcoma	0.000147	0.000269	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CREB1—sarcoma	0.000147	0.000268	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—EGFR—sarcoma	0.000146	0.000266	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NRAS—sarcoma	0.000145	0.000265	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—sarcoma	0.000144	0.000263	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ATF1—sarcoma	0.000143	0.000262	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CREB1—sarcoma	0.000141	0.000258	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KIT—sarcoma	0.00014	0.000256	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—KRAS—sarcoma	0.00014	0.000256	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EGFR—sarcoma	0.000139	0.000254	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KRAS—sarcoma	0.000138	0.000251	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFC—sarcoma	0.000137	0.00025	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EGFR—sarcoma	0.000136	0.000248	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KIT—sarcoma	0.000135	0.000245	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CREB1—sarcoma	0.000133	0.000243	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—EGFR—sarcoma	0.000132	0.000241	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—sarcoma	0.000132	0.00024	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—sarcoma	0.000128	0.000234	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CREB1—sarcoma	0.000128	0.000234	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ENO2—sarcoma	0.000127	0.000232	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—sarcoma	0.000127	0.000232	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HBA1—sarcoma	0.000126	0.000231	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—sarcoma	0.000125	0.000228	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFC—sarcoma	0.000124	0.000227	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MDM2—sarcoma	0.000122	0.000222	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—sarcoma	0.000119	0.000217	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FOXO1—sarcoma	0.000118	0.000216	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PDGFRB—sarcoma	0.000118	0.000215	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—sarcoma	0.000117	0.000214	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—MDM2—sarcoma	0.000117	0.000213	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PDGFRA—sarcoma	0.000116	0.000212	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—sarcoma	0.000112	0.000204	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MDM2—sarcoma	0.00011	0.000201	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FLT1—sarcoma	0.000109	0.0002	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FOXO1—sarcoma	0.000109	0.000199	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—sarcoma	0.000109	0.000199	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PDGFRB—sarcoma	0.000109	0.000199	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—sarcoma	0.000108	0.000197	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PLCG1—sarcoma	0.000108	0.000197	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PLCG1—sarcoma	0.000108	0.000196	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PDGFRA—sarcoma	0.000107	0.000196	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FOXO1—sarcoma	0.000107	0.000195	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PDGFRB—sarcoma	0.000107	0.000195	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—sarcoma	0.000106	0.000194	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—MDM2—sarcoma	0.000106	0.000193	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—JUN—sarcoma	0.000106	0.000193	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PDGFRA—sarcoma	0.000105	0.000192	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CTNNB1—sarcoma	0.000105	0.000192	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCR4—sarcoma	0.000103	0.000189	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ATF1—sarcoma	0.000102	0.000187	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FLT1—sarcoma	9.93e-05	0.000181	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PLCG1—sarcoma	9.76e-05	0.000178	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—JUN—sarcoma	9.59e-05	0.000175	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CTNNB1—sarcoma	9.52e-05	0.000174	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—SRC—sarcoma	9.49e-05	0.000173	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCR4—sarcoma	9.38e-05	0.000171	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ATF1—sarcoma	9.27e-05	0.000169	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—sarcoma	9.13e-05	0.000167	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SRC—sarcoma	9.11e-05	0.000166	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KIT—sarcoma	9e-05	0.000164	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—sarcoma	8.77e-05	0.00016	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—sarcoma	8.6e-05	0.000157	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CREB1—sarcoma	8.57e-05	0.000156	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—sarcoma	8.32e-05	0.000152	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KIT—sarcoma	8.31e-05	0.000152	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—sarcoma	8.28e-05	0.000151	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—sarcoma	8.26e-05	0.000151	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KIT—sarcoma	8.16e-05	0.000149	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1R—sarcoma	8.02e-05	0.000146	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—sarcoma	7.99e-05	0.000146	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—sarcoma	7.95e-05	0.000145	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CREB1—sarcoma	7.91e-05	0.000144	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—sarcoma	7.86e-05	0.000143	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CREB1—sarcoma	7.77e-05	0.000142	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FOXO1—sarcoma	7.64e-05	0.000139	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PDGFRB—sarcoma	7.62e-05	0.000139	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—sarcoma	7.54e-05	0.000138	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—sarcoma	7.54e-05	0.000138	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PDGFRA—sarcoma	7.5e-05	0.000137	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1R—sarcoma	7.28e-05	0.000133	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—sarcoma	7.24e-05	0.000132	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—sarcoma	7.12e-05	0.00013	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MDM2—sarcoma	7.09e-05	0.000129	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FOXO1—sarcoma	6.93e-05	0.000126	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFRB—sarcoma	6.91e-05	0.000126	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—sarcoma	6.84e-05	0.000125	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFRA—sarcoma	6.81e-05	0.000124	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—sarcoma	6.68e-05	0.000122	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MDM2—sarcoma	6.54e-05	0.000119	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MDM2—sarcoma	6.43e-05	0.000117	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—sarcoma	6.41e-05	0.000117	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—sarcoma	6.33e-05	0.000116	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KDR—sarcoma	6.32e-05	0.000115	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—sarcoma	6.16e-05	0.000112	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—sarcoma	6.11e-05	0.000112	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—sarcoma	6.06e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIT—sarcoma	5.82e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—sarcoma	5.81e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—sarcoma	5.74e-05	0.000105	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KDR—sarcoma	5.73e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—sarcoma	5.65e-05	0.000103	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—sarcoma	5.59e-05	0.000102	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—sarcoma	5.54e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CREB1—sarcoma	5.54e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—sarcoma	5.53e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—sarcoma	5.32e-05	9.7e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIT—sarcoma	5.28e-05	9.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—sarcoma	5.1e-05	9.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CREB1—sarcoma	5.02e-05	9.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—sarcoma	5.01e-05	9.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—sarcoma	4.91e-05	8.96e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—sarcoma	4.84e-05	8.84e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—sarcoma	4.82e-05	8.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MDM2—sarcoma	4.58e-05	8.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—sarcoma	4.58e-05	8.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—sarcoma	4.57e-05	8.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—sarcoma	4.47e-05	8.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—sarcoma	4.39e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—sarcoma	4.22e-05	7.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MDM2—sarcoma	4.16e-05	7.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—sarcoma	4.15e-05	7.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—sarcoma	4.09e-05	7.47e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—sarcoma	3.99e-05	7.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—sarcoma	3.98e-05	7.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—sarcoma	3.95e-05	7.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—sarcoma	3.89e-05	7.1e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—sarcoma	3.71e-05	6.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—sarcoma	3.62e-05	6.6e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—sarcoma	3.61e-05	6.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—sarcoma	3.59e-05	6.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—sarcoma	3.58e-05	6.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—sarcoma	3.57e-05	6.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—sarcoma	3.53e-05	6.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—sarcoma	3.48e-05	6.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—sarcoma	3.44e-05	6.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—sarcoma	3.24e-05	5.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—sarcoma	3.2e-05	5.84e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—sarcoma	3.16e-05	5.76e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—sarcoma	3.13e-05	5.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—sarcoma	3.12e-05	5.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—sarcoma	2.96e-05	5.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—sarcoma	2.9e-05	5.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—sarcoma	2.84e-05	5.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—sarcoma	2.68e-05	4.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—sarcoma	2.63e-05	4.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—sarcoma	2.51e-05	4.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—sarcoma	2.38e-05	4.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—sarcoma	2.28e-05	4.16e-05	CbGpPWpGaD
